Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy

被引:43
|
作者
Hosokawa, Takanori [1 ]
Kurosaki, Masayuki [1 ]
Tsuchiya, Kaoru [1 ]
Matsuda, Shuya [1 ]
Muraoka, Masaru [1 ]
Suzuki, Yuichiro [1 ]
Tamaki, Nobuharu [1 ]
Yasui, Yutaka [1 ]
Nakata, Toru [1 ]
Nishimura, Takashi [1 ]
Suzuki, Shoko [1 ]
Ueda, Ken [1 ]
Nakanishi, Hiroyuki [1 ]
Itakura, Jun [1 ]
Takahashi, Yuka [1 ]
Izumi, Namiki [1 ]
机构
[1] Musashino Red Cross Hosp, Div Gastroenterol & Hepatol, Musashino, Tokyo 1808610, Japan
关键词
Hyperglycemia; Hepatocellular carcinoma; Recurrence; Radio frequency ablation; Survival; BREAST-CANCER CELLS; DIABETES-MELLITUS; RADIOFREQUENCY ABLATION; DISTANT RECURRENCE; RISK-FACTORS; HEPATITIS; TYPE-2; METAANALYSIS; CONSENSUS; IMPACT;
D O I
10.3748/wjg.v19.i2.249
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To evaluate whether metabolic factors are related to distant recurrence of hepatocellular carcinoma (HCC) and survival after curative treatment. METHODS: This retrospective study included 344 patients whose HCC was treated curatively by radio-frequency ablation (RFA) therapy. The mean age was 67.6 years and the mean observation period was 4.04 years. The etiological background of liver disease was hepatitis B virus infection in 30, hepatitis C virus infection in 278, excessive alcohol drinking in 9, and other in 27 patients. The Child-Pugh classification grade was A (n = 307) or B (n = 37). The number of HCC nodules was one in 260, two in 61, and three in 23 patients. For surveillance of HCC recurrence after curative therapy with RFA, patients were radiologically evaluated every 3 mo. Factors associated with distant recurrence of HCC or survival were studied. RESULTS: Inadequate maintenance of blood glucose in diabetic patients was associated with higher incidence of distant recurrence. The 1-, 2-, and 3-year recurrence rates were significantly higher in diabetic patients with inadequate maintenance of blood glucose compared with the others: 50.6% vs 26.8%, 83.5% vs 54.4%, and 93.8% vs 73.0%, respectively (P = 0.0001). Inadequate maintenance of blood glucose was an independent predictor of distant recurrence [adjusted relative risk 1.97 (95% CI, 1.33-2.91), (P = 0.0007)] after adjustment for other risk factors, such as number of HCC nodules [2.03 (95% CI, 1.51-2.73), P < 0.0001] and initial level of serum alpha fetoprotein (AFP) [1.43 (95% CI, 1.04-1.97), P = 0.028]. Obesity was not an independent predictor of recurrence. The incidence of distant recurrence did not differ between diabetic patients with adequate maintenance of blood glucose and non-diabetic patients. Among 232 patients who had HCC recurrence, 138 had a second recurrence. The 1-, 2-, and 3-year rates of second recurrence were significantly higher in diabetic patients with inadequate maintenance of blood glucose than in the others: 9.0% vs 5.9%, 53.1% vs 24.3%, and 69.6% vs 42.3%, respectively (P = 0.0021). Inadequate maintenance of blood glucose in diabetic patients [1.99 (95% CI, 1.23-3.22), P = 0.0049] and presence of multiple HCC nodules [1.53 (95% CI, 1.06-2.22), P = 0.024] were again significantly associated with second HCC recurrence. Inadequate maintenance of blood glucose in diabetic patients was also a significant predictor of poor survival [2.77 (95% CI, 1.38-5.57), P = 0.0046] independent of excessive alcohol drinking [6.34 (95% CI, 1.35-29.7), P = 0.019], initial level of serum AFP [3.40 (95% CI, 1.88-6.18), P < 0.0001] and Child-Pugh classification grade B [2.24 (95% CI, 1.12-4.46), P = 0.022]. Comparing diabetic patients with inadequate maintenance of blood glucose vs the others, the 1-, 2-, and 3-year survival rates were significantly lower in diabetic patients with inadequate maintenance of blood glucose: 92% vs 99%, 85% vs 96%, and 70% vs 92%, respectively (P = 0.0003). CONCLUSION: Inadequate maintenance of blood glucose in diabetic patients is a significant risk factor for recurrence of HCC and for poor survival after curative RFA therapy. (C) 2013 Baishideng. All rights reserved.
引用
收藏
页码:249 / 257
页数:9
相关论文
共 50 条
  • [1] Hyperglycemia is a significant prognostic factor of hepatocellular carcinoma after curative therapy
    Takanori Hosokawa
    Masayuki Kurosaki
    Kaoru Tsuchiya
    Shuya Matsuda
    Masaru Muraoka
    Yuichiro Suzuki
    Nobuharu Tamaki
    Yutaka Yasui
    Toru Nakata
    Takashi Nishimura
    Shoko Suzuki
    Ken Ueda
    Hiroyuki Nakanishi
    Jun Itakura
    Yuka Takahashi
    Namiki Izumi
    World Journal of Gastroenterology, 2013, (02) : 249 - 257
  • [2] Hyperglycemia is a Significant Risk Factor for Recurrence of Hepatocellular Carcinoma After Curative Ablation Therapy and Related to Poor Survival
    Hosokawa, Takanori
    Kurosaki, Masayuki
    Nakanishi, Hiroyuki
    Asahina, Yasuhiro
    Izumi, Namiki
    GASTROENTEROLOGY, 2011, 140 (05) : S924 - S924
  • [3] Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma
    Shinichi Umeda
    Mitsuro Kanda
    Hiroyuki Sugimoto
    Haruyoshi Tanaka
    Masamichi Hayashi
    Suguru Yamada
    Tsutomu Fujii
    Hideki Takami
    Yukiko Niwa
    Naoki Iwata
    Chie Tanaka
    Daisuke Kobayashi
    Michitaka Fujiwara
    Yasuhiro Kodera
    BMC Cancer, 17
  • [4] Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma
    Umeda, Shinichi
    Kanda, Mitsuro
    Sugimoto, Hiroyuki
    Tanaka, Haruyoshi
    Hayashi, Masamichi
    Yamada, Suguru
    Fujii, Tsutomu
    Takami, Hideki
    Niwa, Yukiko
    Iwata, Naoki
    Tanaka, Chie
    Kobayashi, Daisuke
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    BMC CANCER, 2017, 17
  • [5] Metadherin Is a Prognostic Predictor of Hepatocellular Carcinoma after Curative Hepatectomy
    Ahn, Soomin
    Hyeon, Jiyeon
    Park, Cheol-Keun
    GUT AND LIVER, 2013, 7 (02) : 206 - 212
  • [6] Adjuvant Therapy after Curative Treatment for Hepatocellular Carcinoma
    Kudo, Masatoshi
    ONCOLOGY, 2011, 81 : 50 - 55
  • [7] Recurrence of hepatocellular carcinoma after curative ablation therapy
    Yoshida, H
    Tateishi, R
    Shiina, S
    Fujishima, T
    Akamatsu, M
    Obi, S
    Sato, S
    Teratani, T
    Kawabe, T
    Omata, M
    GASTROENTEROLOGY, 2004, 126 (04) : A736 - A737
  • [8] Adjuvant Therapy for Hepatocellular Carcinoma after Curative Treatment
    Jeng, Wen-Juei
    Lin, Chen-Chun
    Chen, Wei-Ting
    Sheen, I-Shyan
    Lin, Chun-Yen
    Lin, Shi-Ming
    DIGESTIVE DISEASES, 2014, 32 (06) : 747 - 754
  • [9] Stem cell factor is a novel independent prognostic biomarker for hepatocellular carcinoma after curative resection
    Wang, Xiuchao
    Ren, He
    Zhao, Tiansuo
    Chen, Jing
    Sun, Wei
    Sun, Yan
    Ma, Weidong
    Wang, Jian
    Gao, Chuntao
    Gao, Song
    Lang, Mingxiao
    Jia, Li
    Hao, Jihui
    CARCINOGENESIS, 2014, 35 (10) : 2283 - 2290
  • [10] Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
    Farinati, Fabio
    Sergio, Adriana
    Giacomin, Anna
    Di Nolfo, Maria Anna
    Del Poggio, Paolo
    Benvegnu, Luisa
    Rapaccini, Gianludovico
    Zoli, Marco
    Borzio, Franco
    Giannini, Edoardo G.
    Caturelli, Eugenio
    Trevisani, Franco
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (10) : 1212 - 1218